| abstract |
The invention relates to a method for the treatment of tuberculosis, comprising administering to a subject in need thereof, a therapeutically effective amount of the compound of Formula 1, (as provided in the description), or a stereoisomer, a tautomer, pharmaceutically acceptable salts thereof, or derivatives thereof, such as esters and ethers. The invention further relates to a pharmaceutical composition comprising the compound of Formula 1, and at least one pharmaceutically acceptable carrier, for use in the treatment of tuberculosis. |